Homocysteic acid (HA) has been established as a pathogen in Alzheimer's disease (AD) in 3xTg-AD model mice. However, it is not established whether HA is involved in the AD pathogenesis in humans. We investigated the relationship between urinary HA levels and Mini-Mental State Examination (MMSE) scores in patients with AD (n = 110, normal =22, AD=88) and found a positive, statistically significant relationship between the two variables (r = 0.39, p =0.00003, n = 110). This relationship was stronger in females. (r = 0.47, p = 0.00008, n = 65 in females; r = 0.39, p = 0.02, n =45 in males). Urinary HA level difference between normal and AD in female was statistical significant (normal:18.4 + 10.6vsAD: 9.1 + 7.2 mM,p<0.01), but this difference of male was not statistical significant. (normal:12.7 + 6 vs AD 8.8 + 7.8). Smoking, hypertension, and diabetes mellitus decreased urinary HA excretion. On the basis of these results, we showed that HA is usually excreted into urine in humans and did not affect brain function in normal individuals. However, when urinary HA excretion was decreased, HA was shown to damage brain function, particularly cognitive ability. To confirm our hypothesis, that is, when urinary HA is suppressed to be excreted into urine, the blood HA level will be increased, we examined the relationship between the urinary HA level and blood HA level in 19 patients. The result was shown that the negative statistical significant relationship between them was observed (r=-0.6, p=0.007, n=19). From this result, the uremic encephalopathy of HA toxicity was confirmed. However it is a question that how the blood HA affected the brain cognitive function.
Introduction
Amyloid treatment in mice has been shown to be successful in recovering memory impairment (1, 2) . However, many human clinical trials on amyloid treatment for Alzheimer's disease (AD) have failed recently(3). This suggests that another pathogenic process must be active in humans. We have recently found that homocysteic acid (HA) is an AD pathogen in 3xTg-AD model mice (with APP, Presenilin and Tau genes) (4). In the present study, we investigated whether the pathogenic action of HA is observed in humans. The results showed that HA is a human AD pathogen as well.
Materials and Methods
The study protocol was approved by the Juntendo University Hospital Ethics Committee, and all patients agreed to the procedure by providing informed written consent. The patient profiles are shown in Table 1 . Urine samples were collected from patients in the hospital and the specific gravity of samples was measured. Urinary HA level was adjusted to that of 1.020 specific gravity.
Urinary HA level
High performance liquid chromatography (HPLC) with an ECD detector was performed using a previous method with modifications (5). HA (4 mg) was added to the urine samples as an internal standard. Urine was diluted 10 times with water, and 20 μl of diluted urine sample was added to the measurement solution, which was composed of 150 μl o-phthaldialdehyde reagent and 150 μl mercaptoethanol. Fifteen minutes after mixing the diluted urine sample with the measurement solution, the sample was injected into the HPLC system. Blood HA level was measured according to the method of (5).
Green tea leaves ingestion 16 Alzheimer's patients (Male5, Female 11) ingested 1 g of green tea leaves at every meal for one month. Before ingestion, their MMSE score and HA level in blood were measured. After one month, these parameters were measured.
Results
Urinary HA levels were significantly higher in normal than that in AD patients of female, but male urinary HA levels were not statistical significant between normal and patients. (Table 2 ).
Urinary HA levels were significantly and positively correlated with Mini-Mental State Examination (MMSE) scores (Fig. 1) . This correlation was stronger in females than in males (Figs. 2 and 3) . From Table 2 , normal female excreted HA more higher than that of male. Some smokers as well as patients with diabetes mellitus (DM) and hypertension (HT) were included in the study. Figures 4 and 5 clearly show that smoking, DM, and HT decreased HA excretion. Fig. 6 shows urinary HA of the mild cognitive impairment (MCI), indicating these urinary HA of MCI were around 20 mM. Fig. 7 shows the disease process of AD. I year was one year after detecting AD. 2 years indicate 2 years after detecting AD. From Fig. 7 , it clearly shows that MCI preceeded AD for 1 year and 2 years, indicating that disease process was clearly showed by their urinary HA level. Table 3 shows the direct effect of green tea leaves ingestion on MMSE score and HA level in blood. Clearly shown in Table 3 , green tea leaves decreased HA level and concomitantly increased MMSE score, indicating that HA is a pathogen in human. Now we are interested in the relationship between the decrease in urinary HA level and the increase in blood HA level. Fig. 8 shows the relationship between urinary HA level and blood HA level in 19 patients. From Fig. 8 , the relationship between them was negative statistical significant was observed (r=-0.6, p=0.007, n=19). From this result, patients showed urinary HA excretion was suppressed and their blood HA level increased, which indicated that patients showed an uremic encephalopathy of HA toxicity.
Discussion
Our results clearly indicate that urinary HA levels were positively correlated with MMSE scores. That is, when HA was excreted sufficiently into urine, cognitive function was normal. However, when HA excretion was decreased, cognitive function was impaired, suggesting that HA retained in the body caused cognitive impairment. This phenomenon was observed in Table 2 . That is, Normal cognitive female persons excretes HA statistically significantly higher than female AD patients. And Fig. 8 shows that the relationship between urinary and blood HA level is the negative statistical significant relation (r=-0.6, p=0.007, n=19), which indicates when the urinary HA excretion was suppressed in patients, the increase in blood HA level was observed. Then our hypothesis, a uremic encephalopathy of HA toxicity was confirmed. However it is still question how the blood HA affected MMSE score. Now some papers showed that exogenous NMDA including HA disrupted Blood Brain Barrier permeability (6,7). Then the increased level of HA in blood can enter into brain by BBB disruption and can suppress the cognitive function, which consequently induces the decrease in MMSE score.
Some studies have recently reported that the kidneys of patients with AD are impaired (8,9), suggesting that the decreased HA excretion due to renal failure could be a pathogenic factor in AD. Also green tea leaves ingestion simply but clearly indicated that HA is a pathogen of Alzheimer's disease in human. However we don't know why green tea leaves decreased HA level. But this effect is a real possible phenomenon, because one of authors (HT) already observed the green tea prevented Alzheimer's cognitive decline(10). Some powerful component of green tea leaves such as a pyrroloquinoline quinine (PQQ) can decrease HA level by inhibiting the HA production, or by stimulating HA metabolism.
Our recent study (4) showed that HA is the AD pathogen in the 3xTg-AD mouse model, but it is unclear whether HA is pathogenic in humans. Our observations reported in this study suggest that HA is related to AD pathogenesis in humans as well.
Recent clinical trials on amyloid treatment for AD have all failed. Because all AD model mice show a successful recovery from cognitive impairment following amyloid treatment, a different pathogenic process for AD must be present in humans. We suggest that this process is related to HA considering that HA does not induce its toxicity in mice (11). However amyloid treatment results in the recovery of cognitive impairment because the brain HA level in mice is very low, and it was not toxic (11). But in humans, the brain HA level is very high. For example, the urinary HA level in mice is in micromolar concentrations (4), whereas that in humans is tens of millimolar concentrations, indicating very high levels of HA in the body. These results suggest that we should not neglect HA toxicity even after amyloid treatment. Our observations also provide other interesting insights that DM and HT decreased the urinary HA level, and these diseases are well-known high risk factors for AD (12,13). Furthermore, smoking decreased urinary HA excretion, and heavy smoking can result in AD (14). Our results suggest that DM, HT, and smoking can induce AD by decreasing urinary HA excretion. It is presently unclear how these pathologies suppress HA excretion. However, it is known that organic anion transporters in the kidney play an important role in the excretion of toxic substances (15). Perhaps DM, HT, and smoking affect this transporter system.
More over, there are many evidences which show the homocysteic acid (HA) involvement in human Alzheimer's pathogenic processes. First Vlassenco et al has reported the possible link between regional aerobic glycolysis and amyloid deposition in normal brain (16).
This phenomenon may be induced by HA. First, HA is known as a neurotransmitter in normal brain (17). Second, HA induced a seizure of immature pup of rat. This brain metabolism was changed to be strong glycolysis. (18). Third, HA is published to be a pathogen of Alzheimer's disease (4) and HA induced amyloid beta42. (5) From these evidences, Vlassenco's report, the possible link between a regional glycolysis and amyloid deposition in normal brain, can be induced by HA, whose brain will be later Alzheimer's one, because HA is a pathogen of Alzheimer's disease. Second, it has reported that homocysteine-lowering by B vitamins slow the rates accelerated brain atrophy in mild cognitive impairment (19). This report shows that homocysteine induced brain atrophy, which induced the neurodegeneration.
But we observed that a physiological level of homocysteine did not induce the neurodegeneration (20), then what did induce the brain atrophy? HA is the possible compound which can induce the brain atrophy. Because HA is produced by homocysteine. Third, some special food, that is, high fat diet and low carbohydrate diet can recover the cognitive impairment of Alzheimer's patient (21). This special food induced the ketone body in human, especially beta-hydroxybutyrate (BHB) was induced (21). This BHB is very similar chemical structure as that of HA and BHB, then can compete HA toxicity, which induces the cognitive impairment (4). In conclusion, our findings indicate that when urinary HA excretion is decreased, HA rises to a toxic level in the body, particularly in the brain. This retention of HA induces the AD pathogenic process and cognitive impairment, suggesting that the pathogenesis of AD is similar to that of uremic encephalopathy.
Moreover, our findings suggest that urinary HA can be used as a biomarker of Alzheimer's disease. That is, first normal person's urinary HA level should be observed and if their urinary HA level will be decreased by around 20 mM , their Alzheimer's process will be started (Fig. 6) . So we should know our normal HA level, because our observation indicates that normal HA level shows strong individual variation. Also our observations indicated that mild cognitive impairment (MCI) patients showed their HA levels were around 20 mM, (Fig. 6 ), indicating that urinary HA level at 20 mM is very useful for detecting first Alzheimer's disease process, because disease process of Alzheimer's disease was started around 20 mM of urinary HA (Fig. 7) . 
